Marketing execs at Fujifilm Medical Systems USA have revamped the company's pricing models for PACS in hopes of extending the reach of Synapse. Fuji's new volume-based site license model considers procedure volume and planned concurrency of use, allowing
Marketing execs at Fujifilm Medical Systems USA have revamped the company's pricing models for PACS in hopes of extending the reach of Synapse. Fuji's new volume-based site license model considers procedure volume and planned concurrency of use, allowing customers unlimited use of the Synapse application, regardless of the number of servers, workstations, and modalities that may be in use. Children's Hospital in Boston has already taken advantage of the pricing scheme to make Synapse available on more than 3000 desktops.
A different Fuji program has been designed to meet the needs of smaller facilities conducting fewer than 45,000 radiological studies per year. The turnkey solution, dubbed the Single Step to Digital program, offers three individual purchase packages combining Synapse, Fuji Computed Radiography, and Fuji DryPix imagers. Options include the purchase of just Synapse, Synapse with Fuji's XG5000 and DryPix 5000, or Synapse with the SmartCR and DryPix 3000.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.